Recormon PS 4000 U.I./0,3 mL Les seringues préremplies Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

recormon ps 4000 u.i./0,3 ml les seringues préremplies

roche pharma (schweiz) ag - epoetinum beta - les seringues préremplies - epoetinum beta 4000 u.i., ureum, natrii chloridum, polysorbatum 20, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dodecahydricus, calcii chloridum dihydricum, glycinum, leucinum, isoleucinum, threoninum, acidum glutamicum, phenylalaninum 0.15 mg, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp. natrium 0.48 mg. - la stimulation de l'Érythropoïèse - biotechnologika

Recormon PS 6000 U.I./0,3 mL Les seringues préremplies Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

recormon ps 6000 u.i./0,3 ml les seringues préremplies

roche pharma (schweiz) ag - epoetinum beta - les seringues préremplies - epoetinum beta 6000 u.i., ureum, natrii chloridum, polysorbatum 20, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dodecahydricus, calcii chloridum dihydricum, glycinum, leucinum, isoleucinum, threoninum, acidum glutamicum, phenylalaninum 0.15 mg, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp. natrium 0.48 mg. - la stimulation de l'Érythropoïèse - biotechnologika

Recormon PS 30'000 U.I./0,6 mL Les seringues préremplies Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

recormon ps 30'000 u.i./0,6 ml les seringues préremplies

roche pharma (schweiz) ag - epoetinum beta - les seringues préremplies - epoetinum beta 30000 u.i., ureum, natrii chloridum, polysorbatum 20, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dodecahydricus, calcii chloridum dihydricum, glycinum, leucinum, isoleucinum, threoninum, acidum glutamicum, phenylalaninum 0.3 mg, aqua ad iniectabile q.s. ad solutionem pro 0.6 ml corresp. natrium 1 mg. - la stimulation de l'Érythropoïèse - biotechnologika

Rebif 22 (HSA-haltige Formulierung) Solution injectable en Seringue pré-remplie Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

rebif 22 (hsa-haltige formulierung) solution injectable en seringue pré-remplie

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.06 mg. - multiple sklerose - biotechnologika

Rebif 44 (HSA-haltige Formulierung) Solution injectable en Seringue pré-remplie Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

rebif 44 (hsa-haltige formulierung) solution injectable en seringue pré-remplie

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.1 mg. - multiple sklerose - biotechnologika

Rebif 8.8 (HSA-haltige Formulierung) Solution injectable en Seringue pré-remplie Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

rebif 8.8 (hsa-haltige formulierung) solution injectable en seringue pré-remplie

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 8.8 µg corresp. 2.4 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.02 mg. - multiple sklerose - biotechnologika

Rebif 8.8 und 22 Solution injectable en Seringue pré-remplie Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

rebif 8.8 und 22 solution injectable en seringue pré-remplie

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - i) 8.8 mcg/0.2 ml: interferonum beta-1a adnr 8.8 µg corresp. 2.4 mio u.i., alcohol benzylicus 1.0 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.01 mg. ii) 22 mcg/0.5 ml: interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika

Rebif 22 Solution injectable en Seringue pré-remplie Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

rebif 22 solution injectable en seringue pré-remplie

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika

Rebif 44 Solution injectable en Seringue pré-remplie Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

rebif 44 solution injectable en seringue pré-remplie

merck (schweiz) ag - interferonum bêta-1a adnr - solution injectable en seringue pré-remplie - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.04 mg. - multiple sklerose - biotechnologika

Puregon 300 I.E. Zylinderampullen pour Pen, solution Injectable Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

puregon 300 i.e. zylinderampullen pour pen, solution injectable

organon gmbh - follitropinum bêta - zylinderampullen pour pen, solution injectable - follitropinum beta 400 u.i., saccharum, natrii citras dihydricus, polysorbatum 20, methioninum, conserv.: alcohol benzylicus 4.8 mg, aqua ad iniectabile q.s. ad solutionem pro 0.480 ml. - stimuler le développement folliculaire chez anovulatoires États et à médicalement assistée reproduktionsprogrammen; stimuler la spermatogenèse - biotechnologika